H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
21%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Lung resection in a neoadjuvant protocol

Jiri Klein, Vladimir Kra‡l, Cestmir Neoral, Tom‡as Bohanes, Rene Aujesky, Vitžezslav Kolek, Ivona Gryg‡arkova, Marian Hajduœch, Tom‡as Tichy

Med Sci Monit 2000; 6(5): CR937-940

ID: 507968


Neoadjuvant therapy was defined as a cytoreductive therapy administered prior to a definitive locoregional treatment - surgical resection. While surgical resection can be curative in patients diagnosed with localized early-stage non-small cell lung cancer, patients with nodal (N1, N2) disease are generally not candidates for exclusive surgery. Inductive therapy can improve the microscopic metastatic disease, eradicate the primary tumor and thereby improve survival.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree